AstraZeneca plc (LON:AZN) had its price objective decreased by Jefferies Group LLC from GBX 5,050 ($65.19) to GBX 4,900 ($63.25) in a research report report published on Friday, April 21st. Jefferies Group LLC currently has a hold rating on the biopharmaceutical company’s stock.
A number of other analysts have also issued reports on the company. Credit Suisse Group AG reaffirmed an underperform rating and issued a GBX 4,000 ($51.63) price target on shares of AstraZeneca plc in a research note on Wednesday, April 19th. JPMorgan Chase & Co. reaffirmed a neutral rating on shares of AstraZeneca plc in a research note on Tuesday, April 18th. Barclays PLC reaffirmed an overweight rating and issued a GBX 6,000 ($77.45) price target on shares of AstraZeneca plc in a research note on Monday, April 10th. Deutsche Bank AG reaffirmed a buy rating and issued a GBX 5,500 ($71.00) price target on shares of AstraZeneca plc in a research note on Friday, April 7th. Finally, HSBC Holdings plc lowered AstraZeneca plc to a reduce rating and set a GBX 4,500 ($58.09) price target on the stock. in a research note on Friday, April 7th. Five analysts have rated the stock with a sell rating, seven have issued a hold rating and nine have given a buy rating to the stock. The company has an average rating of Hold and a consensus target price of GBX 5,001.80 ($64.56).
AstraZeneca plc (LON:AZN) traded down 0.41% on Friday, hitting GBX 5119.00. 2,921,092 shares of the company’s stock traded hands. The stock’s market cap is GBX 64.81 billion. The stock has a 50 day moving average price of GBX 4,801.40 and a 200-day moving average price of GBX 4,560.72. AstraZeneca plc has a 12 month low of GBX 3,680.00 and a 12 month high of GBX 5,505.00.
TRADEMARK VIOLATION WARNING: “AstraZeneca plc (AZN) Price Target Cut to GBX 4,900” was published by Markets Daily and is the sole property of of Markets Daily. If you are viewing this report on another domain, it was copied illegally and reposted in violation of US & international copyright & trademark legislation. The legal version of this report can be accessed at https://www.themarketsdaily.com/2017/05/10/jefferies-group-llc-cuts-astrazeneca-plc-azn-price-target-to-gbx-4900-updated-updated.html.
About AstraZeneca plc
AstraZeneca PLC (AstraZeneca) is a biopharmaceutical company. The Company focuses on discovery and development of products, which are then manufactured, marketed and sold. The Company focuses on three main therapy areas: Oncology, Cardiovascular & Metabolic Disease (CVMD) and Respiratory, while selectively pursuing therapies in Autoimmunity, Infection and Neuroscience.
Receive News & Ratings for AstraZeneca plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AstraZeneca plc and related companies with MarketBeat.com's FREE daily email newsletter.